Showing 12 posts of 552 posts found.

Sanofi says its H1N1 jab effective after one dose

October 2, 2009
Sales and Marketing Sanofi, h1n1

 Sanofi Pasteur, the vaccines division of the Sanofi-Aventis Group, has said its swine flu vaccine is effective after a single …

Sanofi-Aventis acquires French biotech Fovea

October 1, 2009
Sales and Marketing Sanofi, ophth

 Sanofi-Aventis is to acquire Fovea Pharmaceuticals, a privately held French company with a focus on diseases of the eye.Fovea has …

Sanofi on track to deliver flu vaccine

September 30, 2009
Sales and Marketing Sanofi, h1n1

French company Sanofi-Pasteur is on track to deliver its H1N1 flu vaccine over the next two months, chief executive Chris …

Merck sells Merial share, but retains animal health option

September 21, 2009
Sales and Marketing Merck, Merial, Sanofi, animal health

Merck & Co has got rid of its interest in animal health products company Merial prior to the merger with …

Sanofi boosted by Multaq vote of approval

March 19, 2009
Research and Development, Sales and Marketing FDA, Multaq, Sanofi, US

An FDA committee has recommended Sanofi-Aventis' new atrial fibrillation treatment Multaq, the company's most important late-stage drug. The FDA cardiovascular …

Viehbacher sets out vision for diversified Sanofi-Aventis

February 11, 2009
Sales and Marketing Sanofi

Sanofi-Aventis's new chief executive Chris Viehbacher has presented his vision to renew the company, which will include greater investment in …

Sanofi cleared to buy Zentiva

February 11, 2009
Sales and Marketing Sanofi, generics

The European Commission says Sanofi-Aventis can go ahead with its planned acquisition of Czech generics company Zentiva. The Commission had …

Sanofi appoints new finance head

December 11, 2008
Sales and Marketing Sanofi, restructure

Sanofi-Aventis' head of finance and legal affairs Jean-Claude Leroy is to leave the company as new chief executive Chris Viehbacher …

Latest news from Datamonitor

November 3, 2008
Sales and Marketing Acomplia, Sanofi

Acomplia's EU suspension dispels illusion of blockbuster futureThe EMEA has suspended Acomplia due to the risk of serious psychiatric disorders. …

Sanofi seals Zentiva deal with improved offer

September 23, 2008
Sales and Marketing MA, Sanofi, generics

Sanofi-Aventis' acquisition of Czech generics firm Zentiva is back on, after the pharma company increased its offer by nearly 10%. …

Viehbacher leaves GSK for Sanofi

September 10, 2008
Sales and Marketing GSK, Sanofi

Chris Viehbacher is set to leave GlaxoSmithKline for a lead role at Sanofi-Aventis after last year losing out to Andrew …

Latest content